Experience of use of human leukocyte interferon in remittent course of multiple sclerosis
I. A. Zavalishin , В. Т. Khaidarov , М. N. Zakharova , L. S. Adarcheva , А. S. Niyazbekova , V. P. Kuznetsov , D. L. Belyaev , А. А. Babayants
Neurology Bulletin ›› 1997, Vol. XXIX ›› Issue (1-2) : 58 -61.
Experience of use of human leukocyte interferon in remittent course of multiple sclerosis
Results of follow up of 58 patients with remittent type of course of multiple sclerosis, who were treated with human leukocyte interferon for 3 years are presented. Improvement in the course of disease of incidence of aggravation and neurological deficite, normalization of cytokines allows to recommend human leucocyte interferon for treatment of multiple sclerosis.
Neurological archive of Bekhterev
| [1] |
Жученко Т.Д., Завалишин И.А. // Неврология. журнал.—1996.—№ 1.—С.37—44. |
| [2] |
Чекнев С.Б. // Иммунология.—1994.—N 2.—С.9—17. |
| [3] |
Brosnan C.F., Cannella В., Battisfini L. // Neurology.— 1995.—Vol.45.—P.16—22. |
| [4] |
Camenga D.L., Johnson K.P., Milton F. et al. // Arch. Neurol.—1986.—Vol.43.—P.1239—1246. |
| [5] |
Durelli L., Bongyoanni M.R., Cavallo R. // Neurology.— 1994.—Vol.44.—P.406—413. |
| [6] |
Link J., Sоderstrоm. M., Olsson T. et al. // Ann.Neurol.— 1994.—Vol.36.—P.379—386. |
| [7] |
Lucas K., Hohfeld R. // Neurology.—1995.—Vol.45.—P.4—6. |
| [8] |
Miller A., Honigman S. In: Abramsky O., Ovadia H., eds.: Martin Dunitz Ltd. Frontiers in multiple Sclerosis: Clinical Research and Therapy.—1997.—P.195—205. |
| [9] |
Panitch H.S. Drugs.—1992.—Vol.44.—P. 946—962. |
| [10] |
Paty D.W., Li D.K. // Neurology.—1993.—Vol. 43.— P.662—667. |
| [11] |
Selmaj K.,Raine C., Canntlla В. // J.Clin. Invest.—1991.— Vol87.—P. 949—954. |
| [12] |
Sharief M.K., Hentger R. // N.Engl. J. Med.—1991.— Vol.325.—P.467—472. |
Zavalishin I.A., Khaidarov В.Т., Zakharova М.N., Adarcheva L.S., Niyazbekova А.S., Kuznetsov V.P., Belyaev D.L., Babayants А.А.
/
| 〈 |
|
〉 |
PDF
